MedPath

Nexus Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

FDA:10

Drug Approvals

Tirofiban Hydrochloride

Approval Date
Feb 15, 2024
FDA

Emerphed

Approval Date
Feb 14, 2024
FDA

Nelarabine

Approval Date
Dec 27, 2023
FDA

Phenobarbital Sodium

Approval Date
Dec 5, 2023
FDA

Fluorescein

Approval Date
Oct 25, 2023
FDA

Dicyclomine HCl

Approval Date
Sep 22, 2023
FDA

Busulfan

Approval Date
Sep 7, 2023
FDA

Sodium Chloride

Approval Date
Aug 30, 2023
FDA

Procainamide Hydrochloride

Approval Date
Nov 2, 2021
FDA

Prochlorperazine Edisylate

Approval Date
Sep 27, 2021
FDA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy